Amino acid a | OR/HR (95% CI) per SD concentration by follow-up time b | |||
---|---|---|---|---|
Full follow-up | >2 years | >5 years | >10 years | |
EPIC nested case-control study | n = 654 cases, 654 controls | n = 601 cases, 601 controls | n = 505 cases, 505 controls | n = 289 cases, 289 controls |
Glutamine | 0.85 (0.75–0.97) | 0.85 (0.75–0.97) | 0.83 (0.72–0.96) | 0.82 (0.68–0.99) |
Glycine | 0.89 (0.75–1.05) | 0.92 (0.77–1.11) | 0.90 (0.73–1.10) | 0.92 (0.70–1.21) |
Valine | 0.92 (0.78–1.08) | 0.91 (0.77–1.08) | 0.93 (0.77–1.12) | 1.04 (0.82–1.33) |
Proline | 1.06 (0.93–1.20) | 1.09 (0.95–1.24) | 1.08 (0.94–1.25) | 0.96 (0.80–1.15) |
Serine | 0.89 (0.73–1.08) | 0.91 (0.74–1.11) | 0.85 (0.68–1.05) | 0.81 (0.61–1.06) |
Threonine | 0.96 (0.85–1.09) | 0.97 (0.85–1.10) | 0.93 (0.81–1.07) | 0.87 (0.72–1.04) |
Ornithine | 0.88 (0.69–1.13) | 0.98 (0.82–1.17) | 0.98 (0.80–1.20) | 1.03 (0.78–1.36) |
Arginine | 1.02 (0.83–1.24) | 1.04 (0.84–1.28) | 1.07 (0.85–1.35) | 1.02 (0.77–1.36) |
Tyrosine | 0.90 (0.76–1.06) | 0.89 (0.75–1.06) | 0.87 (0.72–1.05) | 0.90 (0.71–1.12) |
Histidine | 0.80 (0.69–0.92) | 0.81 (0.69–0.94) | 0.81 (0.69–0.96) | 0.82 (0.67–1.01) |
Tryptophan | 0.85 (0.64–1.12) | 0.80 (0.59–1.08) | 0.77 (0.55–1.06) | 0.77 (0.52–1.12) |
Phenylalanine | 0.89 (0.77–1.03) | 0.87 (0.75–1.02) | 0.84 (0.71–1.00) | 0.83 (0.67–1.03) |
Methionine | 0.88 (0.69–1.13) | 0.86 (0.67–1.12) | 0.84 (0.64–1.11) | 0.89 (0.65–1.22) |
UK Biobank cohort (N = 111,323) | n = 1221 cases | n = 1042 cases | n = 696 cases | |
Glutamine | 0.95 (0.89–1.01) | 0.94 (0.88–1.01) | 0.98 (0.90–1.06) | |
Histidine | 0.93 (0.87–0.99) | 0.95 (0.88–1.01) | 0.94 (0.87–1.03) |